Literature DB >> 31614213

Mycobacterium tuberculosis Rv0426c promotes recombinant mycobacteria intracellular survival via manipulating host inflammatory cytokines and suppressing cell apoptosis.

Cao Ruan1, Jiang Li1, Jingjing Niu1, Ping Li1, Yu Huang1, Xue Li1, Wei Duan1, Shuangquan Yan1, Junfeng Zhen1, Jianping Xie2.   

Abstract

Tuberculosis (TB), caused by Mycobacterium tuberculosis (Mtb) is still a leading cause of death worldwide. M. tuberculosis has evolved multipronged strategies to subvert host immune defenses and establish an immunologically privileged niche in macrophages. Rv0426c has been predicted to be an effector involved in the Mtb-host interactions. To investigate the potential role played by Rv0426c, we constructed recombinant M. smegmatis strains with heterologous expression of Rv0426c. We observed that Rv0426c recombinants became more susceptible to various stresses by increasing cell wall permeability, however with elevated early survival rate within macrophages. This was accompanied by decreased levels of pro-inflammatory cytokines and host cell apoptosis. The data suggested that Rv0426c was a new player involved in the interactions between Mtb and macrophages.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Apoptosis; Cytokines; Effectors; Macrophages; Mycobacterium tuberculosis

Mesh:

Substances:

Year:  2019        PMID: 31614213     DOI: 10.1016/j.meegid.2019.104070

Source DB:  PubMed          Journal:  Infect Genet Evol        ISSN: 1567-1348            Impact factor:   3.342


  2 in total

Review 1.  Recent Developments in the Application of Flow Cytometry to Advance our Understanding of Mycobacterium tuberculosis Physiology and Pathogenesis.

Authors:  Trisha Parbhoo; Samantha L Sampson; Jacoba M Mouton
Journal:  Cytometry A       Date:  2020-05-21       Impact factor: 4.355

2.  Mycobacterium tuberculosis Rv0309 Dampens the Inflammatory Response and Enhances Mycobacterial Survival.

Authors:  Yongchong Peng; Xiaojie Zhu; Lin Gao; Jieru Wang; Han Liu; Tingting Zhu; Yifan Zhu; Xin Tang; Changmin Hu; Xi Chen; Huanchun Chen; Yingyu Chen; Aizhen Guo
Journal:  Front Immunol       Date:  2022-02-24       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.